GlassScriptPhysician profile
Jack R Uhrig
NPI 1720024557
$14,891.80
in general payments reported to CMS, 2019-2025
54 companies · $1,516 in 2025
The $1,516 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,410 · 2020: $1,599 · 2021: $2,352 · 2022: $2,270 · 2023: $2,617 · 2024: $2,129 · 2025: $1,516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,177 · Education: $84.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,176.59 |
| Education | $84.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,601.37 | 2019-2025 | Farxiga, Breztri, Fasenra |
| Novo Nordisk INC | $2,350.34 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,396.10 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $1,095.32 | 2019-2025 | Evenity, Prolia, Repatha |
| Abbvie INC. | $931.92 | 2019-2025 | Vraylar, Dalvance, Qulipta |
| Janssen Pharmaceuticals, INC | $474.42 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $448.10 | 2019-2025 | Jardiance |
| Medtronic, INC. | $427.61 | 2021-2025 | Linq II, Endurant Iis, Reveal Linq |
| Merck Sharp & Dohme LLC | $419.59 | 2019-2024 | Verquvo, Belsomra, Dificid |
| Bayer Healthcare Pharmaceuticals INC. | $374.41 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $372.32 | 2019-2024 | |
| Abbott Laboratories | $330.35 | 2022-2025 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $312.76 | 2019-2023 | |
| Sunovion Pharmaceuticals INC. | $276.99 | 2019-2022 | |
| Boston Scientific Corporation | $239.92 | 2019-2024 | Watchman Flx, Watchman Access System |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $224.66 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $196.53 | 2019-2025 | Eliquis, Cobenfy |
| Dexcom, INC. | $182.47 | 2022-2025 | Dexcom G6 Transmitter |
| Teva Pharmaceuticals USA, INC. | $180.76 | 2019-2024 | Uzedy |
| Otsuka America Pharmaceutical, INC. | $168.20 | 2020-2024 | Rexulti |
| Grifols USA, LLC | $136.16 | 2020-2025 | Prolastin-C Liquid |
| Exact Sciences Corporation | $135.89 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astellas Pharma US INC | $132.69 | 2019-2023 | Veozah |
| Eisai INC. | $115.23 | 2020-2021 | |
| Radius Health, INC. | $112.05 | 2020-2025 | Tymlos |
| Impulse Dynamics (USA) INC. | $111.86 | 2023-2024 | Optimizer, Optimizer |
| Medtronic Vascular, INC. | $111.43 | 2019-2020 | |
| Irhythm Technologies, INC. | $97.77 | 2022-2023 | Zio Xt Patch |
| Amarin Pharma, INC. | $93.51 | 2019-2020 | |
| Mylan Specialty L.P. | $89.07 | 2019-2023 | Yupelri |
| Lundbeck LLC | $85.06 | 2023-2025 | Rexulti |
| Ucb, INC. | $62.51 | 2019-2020 | |
| Verona Pharma, INC. | $59.42 | 2025 | Ohtuvayre |
| Glaxosmithkline, LLC. | $56.69 | 2019-2023 | Arexvy, Shingrix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $56.12 | 2019-2023 | Xifaxan |
| Viatris Specialty LLC | $43.18 | 2025 | Yupelri |
| Allergan, INC. | $42.16 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $38.22 | 2022 | |
| Antares Pharma, INC. | $37.30 | 2019-2021 | |
| Sanofi Pasteur INC. | $36.54 | 2023 | |
| Ardelyx, INC. | $25.35 | 2025 | Ibsrela |
| Sumitomo Pharma America, INC. | $24.67 | 2023-2024 | Gemtesa, Aptiom |
| Neurocrine Biosciences, INC. | $20.50 | 2022 | |
| Insmed, INC. | $19.88 | 2025 | Arikayce |
| Bardy Diagnostics, INC. | $18.45 | 2022 | |
| Tactile Systems Technology INC | $16.47 | 2022 | |
| Adamas Pharmaceuticals, INC. | $16.10 | 2020 | |
| Vital Connect, INC | $15.85 | 2025 | Vitalpatch Rtm |
| Sun Pharmaceutical Industries INC. | $14.43 | 2021 | |
| Melinta Therapeutics, LLC | $14.39 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $12.36 | 2021 | |
| Amag Pharmaceuticals, INC. | $12.31 | 2021 | |
| Philips North America LLC | $12.20 | 2019 | |
| Ethicon US, LLC | $11.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Uhrig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.